학술논문

Adjuvant atezolizumab after adjuvant chemotherapy in resected stage IB–IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase 3 trial
Document Type
Article
Source
In: The Lancet. (The Lancet, 9 October 2021, 398(10308):1344-1357)
Subject
Language
English
ISSN
1474547X
01406736